chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pain in right arm,  achiness in right shoulder, arm and hand Headache Fever shortness of breath/difficulty getting a breath Nausea lethargy Body aches - neck, shoulders upper back, knees , head, general over all aches Started a few hours after vaccine was given and is still ongoing today 3/31/21.  My fever is down but had fever and chills both of the last 2 nights I took Tylenol 500mg from midnight 3/29/21 and every 3 to 5 hours until about 10 pm 3/30/21
within 30 minutes of shot: dizziness, fast heart beat, hand shaking lasted 30-45 minutes, chills, lasted 30 hours. in 24 hours: headache, congestion, left side of face--gums/teeth starting hurting, teeth got very sensitive. sore left arm. on going side effects as of March 28.  Have lessened a little bit. as of March 30. side effects except  teeth sensitivity has subsided.
First day, I was little bit okay. Next day, I had blurry vision for almost 24 hours and then a fever and my heart was pounding. I could hear my heart. My whole body was really hot. My face turned  red. The high heart beat was scary. It felt like I was having a heart attack or something. This heart condition lasted for 2 days. Weakness in the body was like I never felt before my whole life. Those 12 days I felt like I was gonna die soon. It was nightmare for me. I called the pharmacy and told them the reactions. They did not care about anything. They said wait for day or two, then contact my health care provider. I told them I do not have one. I cannot afford one. I do not have insurance. I never had that experience my whole life. That was scary. For treatment my mother recommend some herds and natural remedies. I do not trust this anymore.
This spontaneous report as received from a medical assistant refers to a 25 year old female patient. On 16-JUL-2013 the patient was vaccinated with PNEUMOVAX23, 0.5 ml, intramuscular in the right arm. Lot number H019992, expiry date 09-DEC-2013. On 16-JUL-2013, the patient experienced redness, swelling and pain at the injection site of her right arm. The patient called the clinic on 17-JUL-2013 to report the reactions. The patient was instructed to apply some ice to her injection site and use Ibuprofen to reduce the swelling and pain. The patient was seen by the medical staff at the clinic on 18-JUL-2013. After she was seen in the clinic the patient was prescribed Cephalexin. The outcome of the events was reported as recovering/resolving. Causality assessment was not provided. Additional information is not expected.
D68.9 COAGULOPATHY, UNSPECIFIED TYPE 12/23/2021 ATRIAL FLUTTER, UNSPECIFIED I95.9 HYPOTENSION 1/29/2022 ATRIAL FLUTTER, UNSPECIFIED R09.02 HYPOXIA 12/23/2021 ATRIAL FLUTTER, UNSPECIFIED D68.9 COAGULOPATHY, UNSPECIFIED TYPE 12/23/2021 PRESENCE OF GASTROSTOMY I95.9 HYPOTENSION 1/29/2022 PRESENCE OF GASTROSTOMY R09.02 HYPOXIA 12/23/2021 PRESENCE OF GASTROSTOMY D68.9 COAGULOPATHY, UNSPECIFIED TYPE 12/23/2021 ATHEROSCLEROSIS I95.9 HYPOTENSION 1/29/2022 ATHEROSCLEROSIS R09.02 HYPOXIA 12/23/2021 ATHEROSCLEROSIS D68.9 COAGULOPATHY, UNSPECIFIED TYPE 12/23/2021 BACTEREMIA I95.9 HYPOTENSION 1/29/2022 BACTEREMIA R09.02 HYPOXIA 12/23/2021 BACTEREMIA D68.9 COAGULOPATHY, UNSPECIFIED TYPE 12/23/2021 ATRIAL FLUTTER, UNSPECIFIED I95.9 HYPOTENSION 1/29/2022 ATRIAL FLUTTER, UNSPECIFIED R09.02 HYPOXIA 12/23/2021 ATRIAL FLUTTER, UNSPECIFIED
gouty arthritis; Pain; stayed in bed all day; This case was reported by a consumer and described the occurrence of gouty arthritis in a 57-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, 1 day after receiving Shingrix, the patient experienced gouty arthritis, pain and bed rest. On an unknown date, the outcome of the gouty arthritis, pain and bed rest were recovered/resolved.   The reporter considered the gouty arthritis, pain and bed rest to be related to Shingrix.  Additional details were provided as follows: The patient was the reporter's mother. The age at vaccination was not reported. The reporter stated that, the patient received her first dose and experienced suspected gouty arthritis, the day after the Shingrix shot. The reporter stated that, could not recall the date, but the patient now fine at the time of reporting, after being in pain. The reporter stated that, no hospitalization or death, patient just stayed in bed all day. The patients thought it was related to Shingrix
Vomiting; This is a spontaneous report received from a contactable consumer, the patient. A 20-year-old non pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP6955) via an unspecified route of administration in the left arm on 29Mar2021 at 10:00 (at the age of 20-years-old) as a single dose for COVID-19 immunisation. The medical history of the patient was not reported. The patient did not have allergies to medications, food, or other products. Concomitant medications of the patient included fluoxetine hydrochloride (PROZAC), cyproheptadine (MANUFACTURER UNKNOWN) and birth control from an unknown date and for unknown indications. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 29Mar2021, the patient experienced vomiting. The patient did not receive any treatment for the reported event. The event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event vomiting was recovering at the time of this report.  No follow-up attempts are needed. No further information is expected.
reported to ED on 4/3 with miscarriage, abdominal pain, vaginal bleeding.  I don't have the info on date of delivery it isn't in the ED providers note.
This case was reported by a consumer and described the occurrence of influenza in a 58-year-old female subject who was vaccinated with influenza vaccine (manufacturer unspecified). A physician or other health care professional has not verified this report. On an unspecified date, "about 20 years ago", the subject received a dose of influenza vaccine (details unknown). Less than a year after vaccination with influenza vaccine "about 20 years ago", the subject experienced influenza, possible allergy and vaccination failure. The subject stated that she "got severe flu after getting a flu shot about 20 years ago." According to the subject, her physician stated she "must be allergic to the base of the flu", but did not specifically say she has an allergy to egg. The subject did not recall the name of the flu vaccine. This case was assessed as medically serious by GSK. At the time of reporting the outcome of the events was unspecified.
Received VAR #2 on 5/16/07 at 2 PM.  On 5/17 at 7 PM patient noticed her arm hurt, was red and hot.  On 5/18 at 1:15 patient walked in to school-based clinic to show us her arm.  LTR of L arm is red (size: 9 cm x 7 cm), hot, a little firm to touch in one area, and slightly swollen.  TX: Ice, Ibuprofen.  If much worse tomorrow go to Urgent Care Clinic.  RTC 5/21, Monday, for F/U.
Initial information received on 25-Sep-2018 regarding an unsolicited valid non-serious case received from a nurse. This case involves a 19 months old female patient who received 0.5 mL dose of vaccines ACT-HIB (lot UI917AA via unknown route in the left thigh expiry date: 30-NOV-2019) with sterile water from Merck lot M041689, Expiration date: 29-Jun-2019 on 21-SEP-2018. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included HEPATITIS A VACCINE for Immunisation. It was an actual medication error due to wrong solution used in drug reconstitution. It was reported that a female patient age 19 months received 0.5 ml of the ACTHIB with sterile water from Merck, not using the 0.4 sodium chloride as they should of. It was reported that She did not have any side effects or problems. Had not gone to the ER or to seek emergency treatment. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive and Module VI of the Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error. Documents held by sender: none.
VAERS completed because of being Tested positive for COVID-19 infection 14 or more days after being fully vaccinated. 1st dose01/10/21 2nd dose02/07/21 Diagnosed covid positive:09/10/2021 Symptom onset:09/10/21 Exposure:Home Symptoms:Asymptomatic
Low grade fever, chills and shaking,  Severe muscle aches to the point of barely being able to get out of bed. Two days later very large raised red area at injection site 3 1/2 inch circle with small bumps and very itchy. Lower than normal blood pressure. Feeling REALLY bad lasted for about 3 days.  Feeling bad for about  a week. Not feeling normal lasted about 2 weeks.
Pt felt feverish, chills, muscle aches, pain/redness/itching at injection site.
J96.00 ACUTE RESPIRATORY FAILURE 7/13/2021 NAUSEA AND VOMITING J96.00 ACUTE RESPIRATORY FAILURE 7/13/2021 ASCITES
Patient complained of tremors, nausea, vomiting, sweats late evening the day of vaccine administration and continued for about 36 hours following vaccination.
Approximately 30 minutes after receiving the Moderna vaccine in my left arm, my entire left arm, face and part of my neck  felt very tingly, tight, and slightly warm for about an hour. My cheeks were also slightly puffy.  The intensity decreased after about an hour from the onset of the effects (1.5 hours after the vaccine.)  After 24 hours my face still feels tingly and tight, but only slightly compared to  the day of the vaccine.  I also have have waves of feeling nauseous about 30 minutes after receiving the vaccine and it continues after 24 hours after receiving the vaccine.
anaphylaxis; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via unspecified route single dose for COVID-19 immunization on 03Apr2021. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient experienced anaphylaxis on an unspecified date. Patient reaction required 2 EPI pen shots and 24 hours of medications on the neuro trauma floor and was still having issues. Outcome of the event was not resolved.   Information about Lot/Batch number has been requested.
felt "terrible" for two days; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the parent.  A female patient received bnt162b2 (BNT162B2), administration date 2021 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: MALAISE (non-serious) with onset 2021, outcome "recovering", described as "felt "terrible" for two days".  Additional information: The caller was concerned about taking the second dose of the vaccine due to the type of reaction that he experienced. He stated that his daughter was a Nurse Practitioner in Sweden, and she just received the second dose of the Pfizer COVID-19 vaccine last weekend and felt "terrible" for two days but now she felt fine. He stated that if he knew he would have that type of reaction he would move forward with receiving the second dose, however he was concerned about his blood pressure dropping and the dizziness. He would like to know if there are any recommendations on receiving the second dose of the Pfizer COVID-19 vaccine after experiencing this sort of reaction with the first dose.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Reporting Per EUA  Covid 19 positive, admitted to hospital, transferred to higher level of care after 3 days for respiratory failure
1. Fever, chills, and body aches starting 12 hours after the shot 2. Swollen lymph nodes in the neck and underarm on the arm that received the shot for about 21 days after the injection
administered with vaccine that experienced more than 1 temperature excursion; administered with vaccine that experienced more than 1 temperature excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (administered with vaccine that experienced more than 1 temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (administered with vaccine that experienced more than 1 temperature excursion) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Feb-2021 at 9:06 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 13-Feb-2021 at 9:06 AM,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced POOR QUALITY PRODUCT ADMINISTERED (administered with vaccine that experienced more than 1 temperature excursion). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (administered with vaccine that experienced more than 1 temperature excursion). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (administered with vaccine that experienced more than 1 temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (administered with vaccine that experienced more than 1 temperature excursion) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Age of the patient was reported as 56.10.  Concomitant medication of the patient was not reported.  Batch number 031L20A underwent temperature excursion on 13-Feb-2021 with temperature of 32 degrees Fahrenheit at 09:00 AM. These vials were moved to fridge on 09-Feb-2021 and beyond use date for the vials was reported as 10-Mar-2021. The vaccines moved to clinic on 13-Jan-2021. Storage condition at the time of the excursion was cooler storage during high-pace COVID-19 vaccination clinic.  Vial was in cooler storage and was not in frozen storage during high-pace COVID-19 vaccination. Vials were only punctured right before administration. Vaccines were not frozen at time of administration and prior to administration. It was reported that each time a vial was put into a cooler, sometimes there was a period of 1 hour or 1 hour and a half approximately, when temperature data logger registered a temperature of 34 or 35 degree Fahrenheit. The reporter reported that, no data logger reports were available and fisher brand traceable temperature monitor was used to record hourly temperatures.  No treatment information was provided by the reporter.   This case was linked to MOD-2022-566976 (Patient Link).
Information has been received for the HPV vaccine pregnancy registry from a registered nurse concerning a 25 year old female patient with a history of birth control pills at the time of conception who on 11-MAY-2009 and on 27-JUL-2009 was vaccinated IM with a 0.5 ml first dose (Lot # 661766/0652X) and second dose (662404/0312Y) of GARDASIL, respectively. It was reported that the patient discovered to be pregnant on 12-AUG-2009 because of a urine pregnancy test performed which was positive. On 12-AUG-2009 an ultrasound was performed for dating purposes only. From the ultrasound it was estimated that the patient was 5 weeks pregnant at the time that the second dose of GARDASIL was administered. The estimated delivery date is 29-MAR-2010. Follow-up information has been received from a registered nurse concerning the patient with a history of an elective termination of a previously pregnancy in 2004. It was reported that on 12-AUG-2009, an ultrasound was performed for dating of pregnancy and revealed a small sub-chorionic bleed. The patient's last menstrual period was 22-JUN-2009. Other medications used during the patient's pregnancy included prenatal vitamins (unspecified). Follow up information was received from a registered nurse concerning a 25 year old female with a history of cervical dysplasia (LEGP 2003) and one previous pregnancy and one elective termination who on 11-MAY-2009 and on 27-JUL-2009 was vaccinated IM with a 0.5 ml first dose (Lot # 661766/0652X) and second dose (662404/0312Y) of GARDASIL, respectively. Other medications used during this pregnancy included prenatal vitamins. During the pregnancy, the patient experienced third trimester elevated blood pressure. The patient had a negative vaginal GBS culture. She was treated with TCA twice for condyloma. It was reported that on 23-MAR-2010 at 39 weeks and 1 day of gestation, the patient gave birth to a normal female infant with no congenital anomalies and no other complications, weighing 7 pounds and 14 ounces with an Apgar score of 4/9. Follow up information was received from a physician via medical records. It was noted that the patient was induced at 39 weeks due to borderline preeclampsia. On 26-MAR-2010, the patient's baby was seen again and she was receiving breastfeeding. The baby's experienced is captured in WAES 0908USA02725B1. No further information is available.
Symptoms started day after shots.  Area has grown gradually more red and swollen since injection.  Arm swollen from mid deltoid to elbow.  No pain, no fever, no warmth.
Within 5 minutes of administering the vaccine, patient became unconscious for 2-3 minutes and slowly became conscious and started responding to our questions.
pt recvd vax & exp flu like sx hives, fever, arthritis joints; these sx have been ongoing for 2 wks;
This non-serious spontaneous case, initially received from other non-health professional on 02-Nov-2018, concerns a 75-year-old, elderly patient of an unspecified gender. It was reported that, the FLUCELVAX QIVc vaccine underwent temperature excursion for the first time. The vaccine was out for around 48 hours it reached 11.6 degree Celsius. On 16-Oct-2018, the patient was administered FLUCELVAX QIVc [route of administration: intramuscular, anatomical location: right deltoid, batch number: 252230, expiry date: 31-May-2019 and dose: not reported] which underwent temperature excursion. At the time of this report, no adverse event was reported. This case 201805468 was crossed linked to original cases 201804863 due to same reporter.
Patient presented to vaccination clinic for 2nd dose COVID vaccine.  Pfizer vaccine administered (0.3ml) via IM injection on this date (4/23/21).   Discovered later in the day that patient received Moderna vaccine as 1st dose.  Therefore, wrong manufacturer vaccine provided to patient in that he should have received Moderna for 2nd dose; not the Pfizer as administered.  Patient did not notify nurse that he had previously received Moderna.  As of this time, no adverse outcome noted.  Attempted to call and notify patient with no answer;  voicemail message left; awaiting return call.
Anxiety. Severe concern about how I felt at the moment, lying in bed. Started at about 2:30 am. An electric feeling. Hard to describe. I thought I might be having a heart attack. It happened several times, resolving to a normal state after 40 min or so, being ok for maybe 1/2 an hour then returning. After 3 or 4 worrisome crescendos, I decided to go to the Emergency Room at 4:30 am. Observed there, released with analysis being it was anxiety, not a heart problem.
Severe headache, nausea, vomiting for Two days, then a week later same symptoms but not as severe
Pulse in 160s ... leveled at 150 ... dizziness, confusion, feeling faint, nausea, chest pain, hard to swallow, hard to breath. Taken to ER via ambulance.
COVID; COVID; This is a spontaneous report received from a contactable reporter (Consumer or other non HCP) from product quality group. The reporter is the patient.  A 73-year-old female patient received BNT162b2 (BNT162B2), on 30Jan2021 as dose 1, single (Lot number: EL9265), on 12Mar2021 as dose 2, single (Lot number: EN6207) and on 16Sep2021 as dose 3 (booster), single (Lot number: 30145BA) at the age of 72 years for covid-19 immunisation. The patient's relevant medical history included: "blood pressure" (unspecified if ongoing), notes: she has been on blood pressure medication for years and has been stable; "back problems" (unspecified if ongoing), notes: States that she has a lot of back problems and was taking some unspecified back medications prior to her back surgery; "back surgery" (unspecified if ongoing), notes: Caller states that she does not do as much as it is after having back surgery a few years ago. Concomitant medication(s) included: LOSARTAN [LOSARTAN POTASSIUM] taken for blood pressure abnormal; AMLODIPINE [AMLODIPINE BESILATE] taken for blood pressure abnormal. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Feb2022, outcome "unknown" and all described as "COVID". Clinical course details: Covid 19 after vaccines: the caller stated that all of her cases of Covid were mild. She first got Covid in Feb2022. Then again, she got it in Jun2022. In June, she took two home tests that were positive and one (withheld) test that was negative; her doctor said to treat as positive though due to the two home tests being positive. She got Covid a third time in Sep2022. The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (Jun2022) positive; (Jun2022) positive; (Jun2022) negative.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202201337648 Same patient/drug/reporter; different dose and event;US-PFIZER INC-202201337806 Same patient/drug/reporter; different dose and event;US-PFIZER INC-202201337161 Same patient/reporter; different drug and event;
Patient had swelling and redness that encompassed entire arm.  Went to emergency room.   During visit was discovered that she was having heart damage.  According to the patient the doctor told her it was from the vaccine.
Received 2nd dose of vaccine and felt near syncopal afterwards, resulting in ED visit. Received 1L of fluid, monitoring, and was discharged home.
Headache, Fever, NauseaVomiting,  nauseas and hot after work yesterday, residual headache, and feeling tired and weak this morning. Narrative:  Other Relevant History:
Fever, sweating, chills, nauseau, throwing up, headache, loss of appetite, dizziness over 36 hours
This spontaneous report as received from a pharmacist refers to a 68 year old female patient. The patient was allergic to anti-inflammatory drugs and opioid analogue derivatives. On 29-JAN-2013 the patient was vaccinated subcutaneously with 0.65 ml ZOSTAVAX (lot # h020000, expiry date 02-FEB-2014). The patient was on unspecified pain medications and unspecified cholesterol medications. The patient developed a reddened area about the size "of a palm" around injection site that was hot and raised. She came back to see the pharmacist on 01-FEB-2013 concerning the reaction. The patient had not seen her physician at the time of reporting. The outcome was unknown. Pharmacist requested a lot check of ZOSTAVAX (lot # h020000, expiry date 02-FEB-2014). The pharmacist also reported another patient who received ZOSTAVAX and develop similar injection site reactions. Additional information is not expected.